BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2770734)

  • 21. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin].
    Povarov LS; Isaeva NN
    Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation of tritium-labelled carminomycin and rubomycin by the isotope-exchange method with tritiated water and the determination of the label stability in aqueous solutions].
    Karpov VL; Dedenkov AN
    Antibiotiki; 1981 Apr; 26(4):257-8. PubMed ID: 7235665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 24. Spectroscopic studies of interaction of chlorobenzylidine with DNA.
    Zhong W; Yu JS; Huang W; Ni K; Liang Y
    Biopolymers; 2001; 62(6):315-23. PubMed ID: 11857270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of carminomycin on the structural integrity, primary susceptibility to radiation damage and the postradiation repair of the cellular DNA-membrane complex in Ehrlich's ascitic carcinoma].
    Paranosenkova VI; Saenko AS
    Antibiotiki; 1981 Apr; 26(4):306-10. PubMed ID: 7235672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of the antitumour alkaloid coralyne with duplex deoxyribonucleic acid structures: spectroscopic and viscometric studies.
    Pal S; Kumar GS; Debnath D; Maiti M
    Indian J Biochem Biophys; 1998 Dec; 35(6):321-32. PubMed ID: 10412225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural organization of copper(II) ions in complexes with DNA.
    Prasał Z
    Acta Biochim Pol; 1986; 33(3):153-67. PubMed ID: 3811748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin.
    Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065
    [No Abstract]   [Full Text] [Related]  

  • 29. [Synthesis and properties of the N-acyl derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Povarov LS
    Antibiotiki; 1980 May; 25(5):333-8. PubMed ID: 7387126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Aleksandrova LG; Rozynov BV; Potapova NP
    Antibiot Khimioter; 1988 Oct; 33(10):729-35. PubMed ID: 3214206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of carminomycin on the structural integrity, primary damage susceptibility and postradiation regeneration of the DNA from Erhlich's ascitic carcinoma].
    Paranosenkova VI; Saenko AS
    Antibiotiki; 1980 Apr; 25(4):289-94. PubMed ID: 7369734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the toxicity of carminomycin 13-cyclohexylidenhydrazone].
    Shepelevtseva NG; Vertogradova TP; Belova IP; Gol'dberg LE
    Antibiotiki; 1983 Feb; 28(2):90-5. PubMed ID: 6838184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
    Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)].
    Trishkina EA; Gershanovich ML; Pavlov KA; Danova LA; Labkovskiĭ BM
    Antibiotiki; 1983 Nov; 28(11):853-8. PubMed ID: 6689116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
    Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
    Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of carminomycin in its preparations by high-performance liquid chromatography].
    Aleksandrova LG; Rubasheva LM; Zbarskiĭ VB; Brazhnikova MG
    Antibiot Khimioter; 1988 Aug; 33(8):574-8. PubMed ID: 3196114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of carminomycin in human serum by fluorometric high-performance liquid chromatography.
    Fandrich SE; Pittman KA
    J Chromatogr; 1981 Apr; 223(1):155-64. PubMed ID: 7251757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Semisynthetic derivatives of daunorubicin and carminomycin: inhibition of DNA synthesis after intravenous administration to mice].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Sep; 33(9):653-7. PubMed ID: 3218988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the binding of YO to [poly(dA-dT)]2 and [poly(dG-dC)]2, and of the fluorescent properties of YO and YOYO complexed with the polynucleotides and double-stranded DNA.
    Larsson A; Carlsson C; Jonsson M
    Biopolymers; 1995 Aug; 36(2):153-67. PubMed ID: 7492743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the effects of carminomycin 13-cyclohexylidenehydrazone and carminomycin on several immunologic responses of the body].
    Malkova IV; Shapovalova SP
    Antibiotiki; 1984 May; 29(5):374-7. PubMed ID: 6378085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.